Schlafen家族蛋白在肿瘤和病毒感染中的研究进展
收稿日期: 2019-12-05
修回日期: 2020-04-28
网络出版日期: 2020-05-07
基金资助
中国医学科学院医学与健康科技创新工程项目资助编号(2018-I2M-3-004 SC)
Progress of SLFN family proteins in tumor and virus infection
Received date: 2019-12-05
Revised date: 2020-04-28
Online published: 2020-05-07
Supported by
Supported by CAMS innovation fund for Medical Sciences No(2018-I2M-3-004 SC)
Schlafen (SLFN)家族基因是在人类与小鼠中首先被发现的具有调控细胞生长及T细胞分化等诸多生物学功能的重要基因。该家族基因在小鼠、马和人等各个物种中广泛存在并具有较高的同源性。研究表明,SLFN蛋白在抑制细胞增殖、驱动减数分裂、调控造血细胞、下调血小板数量及调节免疫应答等方面均起到重要的作用,同时还可抑制HIV-1和流感等病毒复制。此外,SLFN蛋白还被发现与肿瘤的治疗密切相关,可以作为预测肿瘤发展进程和化疗敏感性的分子标记。本文介绍了SLFN家族蛋白的分类、结构和主要特征、定位与功能,重点综述了其在肿瘤和病毒感染等相关领域的研究进展,以期为SLFN蛋白新功能的探究提供新思路,对蛋白发挥作用的可能机制给予提示,并为各相关领域的研究提供参考。
陈淑敏, 马铃, 岑山 . Schlafen家族蛋白在肿瘤和病毒感染中的研究进展[J]. 遗传, 2020 , 42(5) : 444 -451 . DOI: 10.16288/j.yczz.19-311
Schlafen (SLFN) family genes were initially found in humans and rats to regulate cell growth and T cell differentiation, and exist widely in mice, horses, humans and other species and exhibit high homology. Lines of evidence suggest that SLFN proteins play important roles in inhibiting cell proliferation, promoting meiosis, regulating hematopoietic cells, reducing platelet numbers and the immune response, and also exert antiviral functions against several virus species including HIV-1, influenza virus and others. In addition, SLFN proteins have also been found to be closely related to cancer therapy, and act as a molecular marker to predict tumor development and the sensitivity to chemotherapy drugs. In this review, we discuss the classification, structures, characteristics, location and functions of SLFN family proteins, and focus on progress related to tumor and virus infection, aiming to provide new thoughts on exploration of SLFN protein functions and the underlying mechanisms.
Key words： Schlafen; cell proliferation; tumor; virus
| [1] | Schwarz DA, Katayama CD, Hedrick SM . Schlafen, a new family of growth regulatory genes that affect thymocyte development . Immunity, 1998,9(5):657-668. |
| [2] | Lund S, Christensen KV, Hedtj?rn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, P?rzgen P, Leist M . The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol, 2006,180(1-2):71-87. |
| [3] | Geserick P, Kaiser F, Klemm U, Kaufmann SH, Zerrahn J . Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif . Int Immunol, 2004. 16(10):1535-1548. |
| [4] | Razzak M . Genetics: Schlafen 11 naturally blocks HIV . Nat Rev Urol, 2012,9(11):605. |
| [5] | Bustos O, Naik S, Ayers G, Casola C, Perez-Lamigueiro MA, Chippindale PT, Pritham EJ, de la Casa-Esperón E,. Evolution of the Schlafen genes, a gene family associated with embryonic lethality, meiotic drive, immune processes and orthopoxvirus virulence. Gene, 2009,447(1):1-11. |
| [6] | Neumann B, Zhao L, Murphy K, Gonda TJ . Subcellular localization of the Schlafen protein family. Biochem Biophys Res Commun, 2008,370(1):62-66. |
| [7] | Brady G, Boggan L, Bowie A, O'Neill LA. Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1. J Biol Chem, 2005,280(35):30723-30734. |
| [8] | Liu XJ, Lou HQ . Single molecular biology: coming of age in DNA replication. Hereditas(Beijing), 2017,39(9):771-774. |
| [8] | 刘晓晶, 楼慧强 . DNA复制研究步入单分子时代. 遗传, 2017,39(9):771-774. |
| [9] | Omar I, Guterman-Ram G, Rahat D, Tabach Y, Berger M, Levaot N . Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors. Sci Rep, 2018,8(1):13005. |
| [10] | Cui JJ, Tian GS, Tian D, Zeng Z . An integrated biological model for interferon signaling pathway and its gene polymorphisms. Hereditas(Beijing), 2008,30(6):788-794. |
| [10] | 崔建军, 田庚善, 田地, 曾争 . 干扰素信号传导通路与其基因组多态性网络模型的建立. 遗传, 2008,30(6):788-794. |
| [11] | Fischietti M, Arslan AD, Sassano A, Saleiro D, Majchrzak-Kita B, Ebine K, Munshi HG, Fish EN, Platanias LC . Slfn2 regulates type i interferon responses by modulating the NF-κB pathway. Mol Cell Biol, 2018,38(16):e00053-18. |
| [12] | Condamine T, Le Luduec JB, Chiffoleau E, Bériou G, Louvet C, Heslan M, Tilly G, Cuturi MC . Characterization of Schlafen-3 expression in effector and regulatory T cells. J Leukoc Biol, 2010,87(3):451-456. |
| [13] | Walsh MF, Hermann R, Sun KL, Basson MD . Schlafen 3 changes during rat intestinal maturation. Am J Surg, 2012,204(5):598-601. |
| [14] | Patel BB, Yu YJ, Du JH, Rishi AK, Sarkar FH, Tarca AL, Wali A, Majumdar APN . Schlafen 3, a novel gene, regulates colonic mucosal growth during aging. Am J Physiol Gastrointest Liver Physiol, 2009,296(4):G955-G962. |
| [15] | Guo F, Luo ZW, Liu ZY, Li YQ, Li HJ, Zhou TH . Studies of effect of prosaposin on cell proliferation, cell apoptosis and its possible molecular mechanism. Hereditas(Beijing), 2009,31(12):1226-1232. |
| [15] | 郭芬, 罗志文, 刘兆宇, 李月琴, 李泓剑, 周天鸿 . prosaposin对细胞增殖和凋亡的调控及其分子机制. 遗传, 2009,31(12):1226-1232. |
| [16] | Katsoulidis E, Mavrommatis E, Woodard J, Shields MA, Sassano A, Carayol N, Sawicki KT, Munshi HG, Platanias LC . Role of interferon {α} (IFN{α})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. J Biol Chem, 2010,285(51):40333-40341. |
| [17] | Li MQ, Kao E, Gao X, Sandig H, Limmer K, Pavon- Eternod M, Jones TE, Landry S, Pan T, Weitzman MD, David M . Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature, 2012,491(7422):125-128. |
| [18] | Pisareva VP, Muslimov IA, Tcherepanov A, Pisarev AV . Characterization of novel ribosome-associated endoribonuclease SLFN14 from rabbit reticulocytes. Biochemistry, 2015,54(21):3286-3301. |
| [19] | Puck A, Aigner R, Modak M, Cejka P, Blaas D, St?ckl J . Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells. Results Immunol, 2015,5:23-32. |
| [20] | Yang JY, Deng XY, Li YS, Ma XC, Feng JX, Yu B, Chen Y, Luo YL, Wang X, Chen ML, Fang ZX, Zheng FX, Li YP, Zhong Q, Kang TB, Song LB, Xu RH, Zeng MS, Chen W, Zhang H, Xie W, Gao S . Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control. Nat Commun, 2018,9(1):1165. |
| [21] | Saes JL, Simons A, de Munnik SA, Nijziel MR, Blijlevens NMA, Jongmans MC, van der Reijden BA, Smit Y, Brons PP, van Heerde WL, Schols SEM. Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis. Haemophilia, 2019,25(1):127-135. |
| [22] | Stapley RJ, Pisareva VP, Pisarev AV, Morgan NV . SLFN14 gene mutations associated with bleeding. Platelets, 2019,31(3):407-410. |
| [23] | Su W, Wang RC, Lohano MK, Wang L, Zhu P, Luo Y, Guo LJ, Lv Q, Jiang H, Wang JH, Mei L, Weng J, Su L, Dong NG . Identification of two mutations in PCDHGA4 and SLFN14 genes in an atrial septal defect family. Curr Med Sci, 2018,38(6):989-996. |
| [24] | Lee NK, Choi HK, Yoo HJ, Shin J, Lee SY . RANKL- induced schlafen2 is a positive regulator of osteoclastogenesis. Cell Signal, 2008,20(12):2302-2308. |
| [25] | Horton MR, Powell JD . Quieting T cells with Slfn2. Nat Immunol, 2010,11(4):281-282. |
| [26] | Companioni Nápoles O, Tsao AC, Sanz-Anquela JM, Sala N, Bonet C, Pardo ML, Ding L, Simo O, Saqui-Salces M, Blanco VP, Gonzalez CA, Merchant JL . SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. J Gastroenterol, 2017,52(1):39-49. |
| [27] | Kovalenko PL, Basson MD . Schlafen 12 expression modulates prostate cancer cell differentiation. J Surg Res, 2014,190(1):177-184. |
| [28] | Wu XY, Schnitzler GR, Gao GF, Diamond B, Baker AR, Kaplan B, Williamson K, Westlake L, Lorrey S, Lewis TA, Garvie CW, Lange M, Hayat S, Seidel H, Doench J, Cherniack AD, Kopitz C, Meyerson M, Greulich H . Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12. J Biol Chem, 2020,295(11):3431-3446. |
| [29] | Katsoulidis E, Carayol N, Woodard J, Konieczna I, Majchrzak-Kita B, Jordan A, Sassano A, Eklund EA, Fish EN, Platanias LC . Role of Schlafen 2 (SLFN2) in the generation of interferon α-induced growth inhibitory responses. J Biol Chem, 2009,284(37):25051-25064. |
| [30] | Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP . Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. Am J Physiol Gastrointest Liver Physiol, 2011,301(2):G347-G355. |
| [31] | Barretina J, Caponigro G., Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jané- Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 2012,483(7391):603-607. |
| [32] | Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, Ballestrero A, Doroshow JH, Pommier Y . Putative DNA/ RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc Natl Acad Sci USA, 2012,109(37):15030-15035. |
| [33] | Kaur S, Schwartz AL, Jordan DG, Soto-Pantoja DR, Kuo B, Elkahloun AG, Mathews GL, Thomas CJ, Ferrer M, Thomas A, Tang SW, Rajapakse VN, Pommier Y, Roberts DD . Identification of Schlafen-11 as a target of CD47 signaling that regulates sensitivity to ionizing radiation and topoisomerase inhibitors. Front Oncol, 2019,9:994. |
| [34] | Marzi L, Szabova L, Gordon M, Weaver Ohler Z, Sharan SK, Beshiri ML, Etemadi M, Murai J, Kelly K, Pommier Y . The indenoisoquinoline TOP1 inhibitors selectively target homologous recombination-deficient and Schlafen 11- positive cancer cells and synergize with olaparib. Clin Cancer Res, 2019,25(20):6206-6216. |
| [35] | Malone D, Lardelli RM, Li M, David M . Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response. J Biol Chem, 2019,294(40):14674-14685. |
| [36] | Wang J, Zhou JG, Huang CF . Tructure of the PSA promoter and the mechanisms of its expression regulation. Hereditas(Beijing), 2004,26(5):739-744. |
| [36] | 王健, 周建光, 黄翠芬 . PSA启动子结构和表达调控研究进展. 遗传, 2004,26(5):739-744. |
| [37] | Li DR, Chen J, Ai YW, Gu XQ, Li L, Che D, Jiang ZD, Li L, Chen S, Huang HW, Wang JW, Cai T, Cao Y, Qi XB, Wang XD. Estrogen-related hormones induce apoptosis by stabilizing schlafen-12 protein turnover. Mol Cell, 2019, 75(6): 1103-1116. e9. |
| [38] | Lin YZ, Sun LK, Zhu DT, Hu Z, Wang XF, Du C, Wang YH, Wang XJ, Zhou JH . Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism. Virology, 2016,495:112-121. |
| [39] | Valdez F, Salvador J, Palermo PM, Mohl JE, Hanley KA, Watts D, Llano M . Schlafen 11 restricts flavivirus replication. J Virol, 2019. 93(15):e00140-19. |
| [40] | Kane M, Zang TM, Rihn SJ, Zhang F, Kueck T, Alim M, Schoggins J, Rice CM, Wilson SJ, Bieniasz PD . Identification of interferon-stimulated genes with antiretroviral activity. Cell Host Microbe, 2016,20(3):392-405. |
| [41] | Seong RK, Seo SW, Kim JA, Fletcher SJ, Morgan NV, Kumar M, Choi YK, Shin OS . Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication. Immunobiology, 2017,222(11):979-988. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:
